Novartis has quarterly figures coming up. What experts expect.
Novartis will present the figures for the most recent quarter, which ended on December 31, 2025, at the financial conference on February 4, 2026.
On average, 11 analysts estimate that Novartis will report earnings per share of $1.99 for the most recent quarter. In the previous year, the company generated EPS of CHF 1.25 per share.
For the past quarter, 11 analysts are forecasting on average sales of USD 13.72 billion for Novartis, after sales of CHF 11.54 billion were achieved in the same quarter of the previous year.
On average, 24 analysts expect earnings per share of USD 8.93 for the completed fiscal year, whereas CHF 5.21 was reported in the corresponding fiscal previous year. On the sales side, 23 analysts estimate on average that a total of USD 55.45 billion will be generated in the past fiscal year, compared to CHF 44.31 billion in the previous fiscal year.
Editorial team finanzen.net
Selected leveraged products on Novartis
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Novartis
The leverage must be between 2 and 20
Advertising
